7,8-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-benzopyran-4-one | 134178-11-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: 7,8-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-benzopyran-4-one
• 英文别名: 7,8-dihydroxy-2-(3,5-dimethoxy-4-hydroxyphenyl)-4H-chromen-4-one；7,8-Dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromen-4-one
• CAS: 134178-11-3
• 化学式: C₁₇H₁₄O₇
• 分子量: 330.294
• InChiKey: MYEARWVJGJSPPI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  105
• 氢给体数：
  3
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2',3',4'-三羟基苯乙酮 在 硫酸 、 lithium hexamethyldisilazane 作用下， 以 溶剂黄146 为溶剂， 反应 21.0h， 生成 7,8-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-benzopyran-4-one
  参考文献：
  名称：

  A short and facile synthetic route to hydroxylated flavones. New syntheses of apigenin, tricin, and luteolin

  摘要：

  Reaction of the lithium polyanions generated from omicron-hydroxyacetophenones 3a-f with O-silyloxylated benzoates 2a-d gave 1-aryl-3-(2-hydroxyphenyl)-1,3-propanediones 4a-n, which on treatment with acetic acid containing 0.5% H2SO4 at 95-100-degrees-C afforded hydroxylated flavones 5-18 in high yields (76-92%).

  DOI：

  10.1021/jo00016a015

文献信息

• Substituted benzopyranones as telomerase inhibitors
  申请人：——

  公开号：US20020160983A1

  公开（公告）日：2002-10-31

  The present invention relates to benzopyranone derivatives, to methods for treating telomerase-modulated diseases, in particular cancers, with said derivatives, to a process for their preparation, to their use as medicaments and to pharmaceutical compositions comprising them.

  本发明涉及苯并吡喃酮衍生物，涉及使用所述衍生物治疗端粒酶调节疾病的方法，特别是癌症，涉及它们的制备过程，它们作为药物的使用，以及包含它们的药物组合物。
• SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS
  申请人：Pharmacia Italia S.p.A.

  公开号：EP1373244A2

  公开（公告）日：2004-01-02
• [EN] SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS<br/>[FR] BENZOPYRANONES SUBSTITUES UTILISES EN TANT QU'INHIBITEURS DE TELOMERASE
  申请人：PHARMACIA ITALIA SPA

  公开号：WO2002074036A2

  公开（公告）日：2002-09-26

  The present invention relates to benzopyranone derivative, to methods for treating telomerase-modulated diseases, in particular cancers, with said derivatives, to a process for their preparation, to their use as medicaments and to pharmaceutical compositions comprising them.